Kester Nahen, PhD, Joins Notal Vision as Chief Commercial Officer

Source: Notal Vision

Notal Vision has announced the appointment of Kester Nahen, PhD, to Chief Commercial Officer. Dr. Nahen is a medical device industry expert and brings more than 18 years of international business experience in product management, medical science, clinical research, marketing, sales, professional education, and business development to the company.

“I am delighted to welcome Kester to the Notal Vision executive team,” Dr. Susan Orr, Chief Executive Officer of Notal Vision, said in a company news release. “I am confident that his broad ranging acumen in the retina field and OCT technology will play an instrumental role in enhancing and driving our strategy and pipeline. Kester’s contributions will build on our momentum during this pivotal phase in Notal Vision’s growth, and in the future, as we continue to shape Home Diagnostic Services in eye care elevating the physician’s ability to help their patients.”

Prior to joining Notal Vision, Dr. Nahen was Managing Director of ophthalmic diagnostic device manufacturer at Heidelberg Engineering GmbH and served on the board of Heidelberg Engineering Inc. He co-led the organization through over 10 years of strong growth fueled by the strategic alignment of the Spectralis OCT imaging platform with the availability of innovative pharmacologic treatment solutions. From 2001 to 2006, Dr. Nahen worked at Laserscope Inc., a Silicon Valley-based medical laser company. Dr. Nahen was member of the AMS/Laserscope merger executive team culminating in selling Laserscope 45% over market cap at a price of $715 million. He received his PhD in Physics from the Medical University of Lübeck, Germany.

Dr. Nahen has repeatedly demonstrated effective leadership in cross-functional research, product development and marketing teams. A passionate marketer of high-performance medical devices, he propelled the adoption of new standards of care in retina disease management. A valued partner with industry and academia in clinical research collaborations as well as business development activities, Dr. Nahen is known for his technical and clinical expertise in ophthalmic imaging.

“Notal Vision is a true pioneer in home diagnostic services that extend eye disease management from the clinic to the home and improve vision outcomes, and I’m honored to be joining this cutting-edge organization,” Dr. Nahen said in a company news release. “I have tremendous respect for Susan Orr and her leadership team and look forward to working with such a talented group of individuals and the ophthalmic community to advance our engagement solution and technology. By applying artificial intelligence (AI)-driven data interpretation to the unprecedented high volumes of data generated by patients at home, the company is redefining eye care with precision medicine. We can enable treatment decisions consistent with the timing of each patient’s disease activity rather than pre-scheduled clinic appointments.”


Related Content